The chart below shows how OXBR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, OXBR sees a -8.14% change in stock price 10 days leading up to the earnings, and a +34.23% change 10 days following the report. On the earnings day itself, the stock moves by -7.00%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Net Premiums Earned Growth: 1. Increased Net Premiums Earned: Net premiums earned for Q3 2024 were $595,000, up from $549,000 in Q3 2023, and for the first nine months of 2024, they reached $1.7 million, compared to $730,000 in the same period last year.
Revenue Recovery Highlights: 2. Significant Revenue Improvement: Total revenues for Q3 2024 were $205,000, a substantial recovery from negative $6.38 million in Q3 2023, and for the first nine months of 2024, total revenue was $124,000 compared to negative $5.1 million in the prior year.
Zero Loss Ratio Achievement: 3. Zero Loss Ratio: The company reported a loss ratio of 0% for both Q3 2024 and Q3 2023, indicating no losses or loss adjustment expenses incurred in either period.
Expense Ratio Improvement: 4. Decreased Expense Ratio: The expense ratio improved significantly from 125.3% in Q3 2023 to 83.7% in Q3 2024, reflecting higher premium levels and lower general administrative expenses.
Tokenized Securities Success: 5. Successful Tokenized Securities Offering: SurancePlus completed a private placement of over 287,705 participating shares, raising approximately $2.9 million, demonstrating strong investor interest and confidence in their new offerings.
Negative
Improved Net Loss: 1. Net Loss: The company reported a net loss of $548,000 for Q3 2024, compared to a net loss of $10.3 million in Q3 2023, indicating ongoing financial challenges despite improvements.
Investment Income Decline: 2. Decreased Investment Income: Net investment and other income decreased due to less cash held in money market funds, contributing to financial strain.
Investment Value Decline: 3. Unrealized Losses: The company recorded an unrealized loss of $1.93 million on other investments, reflecting a significant decline in investment value.
Investment Portfolio Decline: 4. Decline in Investment Portfolio: The investment portfolio decreased to $185,000 at September 30, 2024, down from $680,000 at the prior year-end, indicating a substantial reduction in asset value.
Rising Acquisition Costs: 5. Increased Acquisition Cost Ratio: The acquisition cost ratio increased to 11.1% for Q3 2024 from 10.9% in Q3 2023, suggesting rising operational inefficiencies despite higher premium levels.
Oxbridge Re Holdings Limited (OXBR) Q3 2024 Earnings Call Transcript
OXBR.O
-0.55%